Skip to main content

US ClosedU.S. Closed

KURA: Kura Oncology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Kura Oncology, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

52W Range

81stpctl

Volume

1.01×avg

Market Cap

1.12BUSD

P/E Ratio

-3.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Kura Oncology, Inc.

KURANASDAQ·USD·Closed

Kura Oncology, Inc.

KURANASDAQ·USD·Closed

$12.66

−3.95%

$12.66

−$0.52 (3.95%)

52W Range

81stpctl

Volume

1.01×avg

Mkt Cap

1.12BUSD

P/E

-3.8TTM

Div Yield

–ann